• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL LTD BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Model Number 142122-15
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Discomfort (2330); Restenosis (4576)
Event Date 02/02/2023
Event Type  Injury  
Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review has been performed of the manufacturing certificate of conformance associated with this lot.There were no non-conformances or deviations which could be associated with this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of restenosis leading to intervention and leg pain/claudication are listed in the biomimics 3d instructions for use and are known patient effect of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available, a follow-up report will be submitted.
 
Event Description
The patient was treated as part of the mimics 3d usa post-market observational study.On the (b)(6) 2022, the patient was implanted with one biomimics 3d (bm3d) stent (a 7.0 x 125mm stent) to treat a denovo lesion of the superficial femoral artery (sfa) proximal third in the right leg.A contralateral approach was used and the lesion was pre-dilated with percutaneous transluminal angioplasty (pta) and atherectomy.The treated segment was post-dilated with pta.The site reported that on (b)(6) 2023, a restenosis of treated segment (target lesion) was identified.The patient was seen in the clinical office on (b)(6) 2023 with some right leg discomfort.Duplex ultrasound (dus) showed high-grade velocities in proximal and mid sfa with significant dropping flows distal to this and decreasing ankle brachial indexes (abis).A right leg angiogram was conducted on (b)(6) 2023.The event was successfully treated with medication and percutaneous intervention, which involved a pta / standard balloon angioplasty of the sfa proximal third and anterior tibial artery on(b)(6) 2023 with good results.It was reported as a target lesion revascularisation (tlr) / target vessel revascularisation (tvr).The event of restenosis was reported as possibly related to the device and not related to the procedure.It was reported as target lesion related.The patient outcome was reported as resolved/recovered and the device remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL LTD
unit 11 galway technology park
parkmore road
galway, H91 V E0H
EI  H91 VE0H
Manufacturer Contact
alan mcdonagh
unit 11 galway technology park
parkmore road
galway, H91VE-0H
EI   H91VE0H
MDR Report Key16479206
MDR Text Key310619464
Report Number3011632150-2023-00028
Device Sequence Number1
Product Code NIP
UDI-Device Identifier05391526850497
UDI-Public(01)05391526850497(17)221007(11)210308(10)0000076765
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/07/2022
Device Model Number142122-15
Device Catalogue Number142122-15
Device Lot Number0000076765
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ASPIRIN.; CLOPIDOGREL (PLAVIX).
Patient Outcome(s) Required Intervention;
Patient Age51 YR
Patient SexMale
Patient Weight91 KG
-
-